Abstract
p73, a protein that has substantial structural and functional similarity to p53, has recently been identified. It was found to be monoallelically expressed in all cell lines and normal individuals tested. To elucidate its role in cancer development and as a potential imprinted tumor suppressor, we investigated the allele-specific expression of the human p73 gene in 28 cases of renal cell carcinoma and its imprinting status in fetal pancreatic and thymic tissues. Of 12 informative pairs of renal cell carcinoma and matched normal tissues identified by StyI restriction fragment length polymorphism (RFLP) in exon 2, p73 showed monoallelic expression in 11 out of 12 normal tissues but biallelic expression in 8/12 and switched allele expression in 2/12 of the matched corresponding cancers. An imprinting study of the p73 gene in two families using a newly identified exonic BanI RFLP indicated that expression of p73 was limited to the maternal allele in RNA from fetal pancreas and thymus, demonstrating that p73 is imprinted in at least these two tissues. These findings strongly suggest that loss of imprinting or switching of allelic expression of the p73 gene is associated with the development of renal cell carcinoma.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mai, M., Qian, C., Yokomizo, A. et al. Loss of imprinting and allele switching of p73 in renal cell carcinoma. Oncogene 17, 1739–1741 (1998). https://doi.org/10.1038/sj.onc.1202099
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1202099
Keywords
This article is cited by
-
Association between PEG3 DNA methylation and high-grade cervical intraepithelial neoplasia
Infectious Agents and Cancer (2021)
-
Targeting Epigenetic Aberrations in Esophageal Squamous Cell Carcinoma
Current Pharmacology Reports (2020)
-
PEG1/MEST and IGF2 DNA methylation in CIN and in cervical cancer
Clinical and Translational Oncology (2014)
-
Neuropathology of brain and spinal malformations in a case of monosomy 1p36
Acta Neuropathologica Communications (2013)
-
Association of the p73 gene G4C14-to-A4T14 polymorphism with increased gastric cancer risk in a northwestern Chinese population
Chinese Journal of Clinical Oncology (2008)